Endometrial Neoplasms
4 competing products in clinical development for Endometrial Neoplasms.
Pipeline by Phase
Phase 1/21
Phase 33
All Products (4)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Lenvatinib + Pembrolizumab + Paclitaxel + Carboplatin | Eisai | Phase 3 | Completed | 40 |
| Pembrolizumab + Lenvatinib + Paclitaxel + Doxorubicin | Eisai | Phase 3 | Completed | 40 |
| Lenvatinib + Pembrolizumab + Paclitaxel + Carboplatin | Eisai | Phase 3 | Completed | 40 |
| E7386 + Lenvatinib + Doxorubicin + Paclitaxel | Eisai | Phase 1/2 | Active | 36 |